Navigation Links
Great Lakes NeuroTechnologies Awarded Patent For Sensor Based Continuous Parkinson's Assessment During Daily Activities

VALLEY VIEW, Ohio, Dec. 3, 2013 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor symptoms associated with movement disorders such as Parkinson's disease. The claims cover a system and method including a continuously worn sensor to detect movement, trained algorithms for distinguishing voluntary movement from involuntary movement, and automated scoring of the severity of symptoms correlated in part to traditional clinician rating scales. Continuous monitoring of Parkinson's can capture daily fluctuation in disease states in ambulatory settings and patient homes.  However, continuous assessment using movement sensors provides significant challenges as some activities may interfere with or mimic the actual movement disorder motor symptoms.  Intelligent algorithms can differentiate normal movements from Parkinson's symptoms, as well as rate the severity of symptoms that are present.

Millions of people around the world are impacted by a growing incidence of movement disorders such as Parkinson's disease.  Great Lakes NeuroTechnologies is committed to the commercialization of new medical technologies to visualize quantitative symptom response and improve patient access to care through telemedicine applications such as Kinesia [ ]. "Much of our previous work has focused on remote assessment of Parkinson's symptoms during specific tasks completed at regular intervals during the day. Patients interact with a touchscreen tablet while wearing a motion sensor and following video instructions. While this provides high sensitivity measurement during known tasks, more continuous assessment also has significant advantages," says Chris Pulliam, PhD, Senior Biomedical Researcher. "Allowing a patient to comfortably wear a sensor and just go about their daily life can minimize burden and provide insight on symptoms during normal daily activities.  The key however, is how to distinguish between whether someone is typing or has tremor, or if someone is folding the laundry or has dyskinesias. Over the last year, we have made great strides developing advanced algorithms for assessing motor symptoms during these everyday activities." Dr. Pulliam also thanked the National Institute on Aging for their continued support of these technologies, and more specifically for Phase II SBIR (5R44AG034708-03) which is currently supporting clinical validation of the technology at Rush University Medical Center and Baylor University.   

This is the second allowance of important patent claims received by Great Lakes NeuroTechnologies in 2013.  Their growing intellectual property portfolio is being fueled by a team of principal investigators with significant funding from the National Institute of Health. "Continuing to broaden our intellectual property and strengthening our pipeline of submitted applications will help protect both our domestic and international target markets," says Brian Kolkowski, PhD, Executive Vice-President and General Counsel. "The system, method, and intelligent algorithms behind our continuous monitoring technology represent a key feature for our company's strategic growth."

About Great Lakes NeuroTechnologies 
Great Lakes NeuroTechnologies [ ] is committed to pioneering innovative biomedical technologies to serve research, education, and medical communities, improving access to medical technology for diverse populations, and positively impacting quality of life for people around the world.

Media Contact
Amelia Earhart, 216-361-5410 -

SOURCE Great Lakes NeuroTechnologies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
2. The Greater Gift Initiative Reaches Milestone of 25,000 Vaccines
3. Clinical Conductor CTMS Partners with the Greater Gift Initiative to Donate Vaccines
4. The Great E2 Hand Soap Challenge Asks Food Processors and Food Handlers: How Good is the E2 Hand Soap You’re Currently Using?
5. Bayer CropScience Supports 10th Anniversary of United Way Of The Greater Triangle’s Girls’ Leadership Development Initiative
6. FarHawk Marketing Services Represents IonBench™ and MS Noise™ at the Greater Boston Mass Spectrometry Discussion Group Corporate Night October 3rd
7. Exotic Automation & Supply to Exhibit at the 2013 Great Lakes Truck Expo
8. How to Grow a Great Garden--With Less Pain: Tips From Topical BioMedics
9. Vital Imaging Makes Greater Commitment into MRI Research
10. Fidelis Companies Launches Rebrand: New Look, Same Great Company
11. Rudy Mazzocchi Joins the Greatbatch Board of Directors as he Continues to Expand his Presence in the Med-tech Industry
Post Your Comments:
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... -- Connected health pioneer, Joseph C. Kvedar , MD, ... and wellness, and the business opportunities that arise from ... of Healthy Things . Long before health and ... Kvedar, vice president, Connected Health, Partners HealthCare, was creating ... from the hospital or doctor,s office into the day-to-day ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):